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We thank Drs Kim and Grzybowski for their interest in our paper1 and for highlighting their concern 
about the lack of strict diagnostic criteria for macular edema and the lack of preoperative OCT scans 
which might have affected the quality of case reporting of pseudophakic macular edema (PME) in 
our study. 
We fully agree that strict selection of diagnostic criteria is needed in prospective studies designed to 
answer specific questions about the change in macular status between preoperative and 
postoperative periods.  In our study, the aim was to describe in the real world setting, how 
frequently clinicians were encountering PME and documenting it in everyday practice on an 
electronic patient record (EPR) system.  Therefore a retrospective design with a large and 
representative cohort of consecutive patients was ideal for this purpose with the two most crucial 
factors in determining accuracy of case reporting being: i) the ability of clinicians to make a diagnosis 
of macular edema in everyday practice following cataract surgery and ii) the reliability of those 
clinicians at making an entry onto the EPR system.  We felt confident that in all our sites (which had 
experienced clinicians, spectral domain OCT facilities and robust cataract management pathways), 
these two systematic causes of potential under-reporting were unlikely to be significant.  We were 
further reassured as our results were similar to other database studies which focussed on real world 
outcomes.2,3   
We agree with their comment that comparison of pre and post preoperative OCT scans is essential 
for quantitative assessment of the effect of cataract surgery on macular edema, and note Dr Kim’s 
prospective study on 50 eyes of patients with diabetes4, which reported increasing macular 
thickening with diabetic retinopathy grade and we are pleased to have been able to subsequently 
demonstrate his findings in a large real-world context.  It was our aim to quantify and compare the 
rates of PME between eyes with not only diabetic retinopathy but also other co-morbidities.  The 
unique feature in our study was the availability of accurately documented data fields on several risk 
factors for PME in a very large consecutive cohort of eyes undergoing cataract surgery in a real world 
setting.  We are unaware of any similar study providing quantitative comparisons between the 
different risk factors for PME that are encountered in everyday clinical practice. 
We are grateful to Drs Kim and Grzybowski for highlighting the fine details of methodology in our 
study.  A high standard of rigour is important in explanatory, prospective studies using strict 
protocols on very homogenous groups of patients to answer questions which further our scientific 
knowledge.  Indeed, it is equally important in pragmatic trials and real world studies which inform us 
of the experiences and outcomes of everyday clinical practice and are valuable for clinical decision 
making and the development of guidelines and policies.6-9 The PME incidence rates of between 
1.17% to 12.07% pose a significant morbidity risk when one considers the much lower risks of other 
complications such as posterior capsule rupture in modern cataract surgery.  It is possible that this 
kind of real world evidence could influence policy makers to introduce preoperative OCT scanning 
and even prophylactic therapy such as topical bromfenac or nepafenac which are currently not 
recommended in clinical guidelines.10,11 
 
Colin J Chu, Robert L Johnston, Charlotte Buscombe, Ahmed B Sallam, Quresh Mohamed and Yit C 
Yang for the United Kingdom Pseudophakic Macular Edema Study Group. 
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